For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Smart thinking proves a lockdown lifeline
Wednesday 26 May 2021, 01:15 AM

The Blind Low Vision NZ team. Back row: John Mulka, Mark Dickinson, Dan Shepherd, Israel Coello, Nigel Waring and Hendrik Verbeek. Front row: Sefulu Calvert, Liz Ansell and Marjorie Hawkings
PHARMACEUTICAL SOCIETY INNOVATION IN SERVICE DELIVERY AWARD
This award recognises a forward-thinking person or people who have made primary healthcare services significantly better through new ideas and initiatives. Their innovation might have enabled healthcare to continue during a period of uncertainty or significantly improved patient experiences, access and equity etc. The innovation could be clinical, business oriented, technological or other, but should be revolutionary!
Kiwis living with sight loss were supported during COVID-19 lockdowns thanks to creative solutions developed by Blind Low Vision NZ.
The service tr
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.